Porvair (LON:PRV – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at Deutsche Bank Aktiengesellschaft in a research report issued on Thursday, Digital Look reports. They presently have a GBX 1,050 target price on the stock. Deutsche Bank Aktiengesellschaft’s target price indicates a potential upside of 19.59% from the stock’s current price.
Separately, Berenberg Bank dropped their price objective on shares of Porvair from GBX 1,050 to GBX 1,000 and set a “buy” rating for the company in a research note on Thursday. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, Porvair currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 1,025.
Read Our Latest Stock Report on Porvair
Porvair Trading Up 0.5%
Insiders Place Their Bets
In other news, insider Hooman Caman Javvi bought 5,567 shares of Porvair stock in a transaction dated Thursday, October 15th. The shares were acquired at an average price of GBX 890 per share, with a total value of £49,546.30. Also, insider James Mills bought 3,897 shares of the stock in a transaction dated Thursday, October 15th. The stock was purchased at an average price of GBX 890 per share, with a total value of £34,683.30. Insiders own 1.83% of the company’s stock.
About Porvair
Porvair plc engages in the filtration, laboratory, and environmental technology business. It operates through three segments: Aerospace & Industrial, Laboratory, and Metal Melt Quality. The Aerospace & Industrial segment designs and manufactures a range of specialist filtration equipment for aerospace, energy, and industrial applications. The Laboratory segment is involved in the design and manufacture of instruments and consumables for use in environmental and bioscience laboratories with a focus on water analysis instruments, diagnostics, and sample preparation equipment.
Featured Articles
- Five stocks we like better than Porvair
- Women Drive the Job Market—These 3 Stocks Are Following Them
- 2026’s ETF Boom Is Approaching 2,000 Launches: Watch These 3
- Microsoft’s New AI Chip Could Change the Economics of AI
- What a Mixed Midterm Result Could Mean for These 2 Health Care ETFs
Receive News & Ratings for Porvair Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Porvair and related companies with MarketBeat.com's FREE daily email newsletter.
